The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Abstract
Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 and BRCA2 suggests that they are involved in two fundamental cellular processes: DNA damage repair and transcriptional regulation. We evaluate current knowledge of BRCA1 and BRCA2 functions to explain why mutations in BRCA1 and BRCA2 lead specifically to breast and ovarian cancer. The BRCA1 and BRCA2 genes contain unusually high densities of repetitive elements. These features of the BRCAs genomic regions contribute to chromosomal instability of these genes. We propose that somatic alterations of BRCA1 and BRCA2 are common and driven by rearrangements between repetitive elements. Inherited and somatic mutations occur in BRCA1 and BRCA2; virtually all somatic mutations are the result of large genomic rearrangements. What are the consequences of such large somatic mutations of BRCA1 and BRCA2 in women with or without inherited mutations? The breast and ovary are estrogen-responsive tissues. Beginning in puberty, the breast epithelium proliferates rapidly in response to fluctuating levels of estrogen. We present a genetic model outlining how BRCA-deficient cells may gain uncontrolled proliferation leading to tumor formation. Central to this model of BRCA-mediated tumorigenesis are estrogen-mediated proliferation of breast and ovarian epithelium and the distinctive genomic context of the BRCA genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mendelian subtypes of common diseases [such as breast cancer (15), hypertension (16), and diabetes (17)] were elucidated, but mutations in these genes explained few cases in the population.”
From Genetic Mapping in Human Disease (2008) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K. N., Seal, S., Tran, T. D., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,918
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Cancer risks in BRCA2 mutation carriers.
Olsson, H. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,404
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Xu, X., Wagner, K., Larson, D. M., Ohler, Z. W., Li, C., Ried, T., Hennighausen, L. G., Wynshaw-Boris, A. J., & Deng, C. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 766
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. J. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 743
Jensen, D. E., Proctor, M. L., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 725
In search of the tumour-suppressor functions of BRCA1 and BRCA2
Scully, R., & Livingston, D. M. (2000) · Nature · doi:10.1038/35044000 · Cited by 643
Pattern formation by local self-activation and lateral inhibition
Meinhardt, H., & Gierer, A. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8 · Cited by 629
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Human genome organization: Alu, LINES, and the molecular structure of metaphase chromosome bands
Korenberg, J. R., & Rykowski, M. C. (1988) · Cell · doi:10.1016/0092-8674(88)90159-6 · Cited by 560
Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
Harkin, D. P., Bean, J. M., Miklos, D. B., Song, Y., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80769-2 · Cited by 558
An entire functional mammary gland may comprise the progeny from a single cell
Kordon, E. C., & Smith, G. H. (1998) · Development · doi:10.1242/dev.125.10.1921 · Cited by 553
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Bochar, D. A., Wang, L., Beniya, H., Kinev, A. V., Xue, Y., Lane, W. S., Wang, W., Kashanchi, F., & Shiekhattar, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00030-1 · Cited by 546
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J., Collins, K. M., Brown, A. L., Lee, C. H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
BRCA1 inhibition of estrogen receptor signaling in transfected cells.
Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M., Pestell, R., Yuan, F., Auborn, K., Goldberg, I., et al. (1999) · Science · doi:10.1126/science.284.5418.1354 · Cited by 521
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
BRCA1 physically associates with p53 and stimulates its transcriptional activity
Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B. L., & El‐Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201932 · Cited by 492
BRCA1 is a component of the RNA polymerase II holoenzyme
Scully, R., Anderson, S. F., Chao, D. M., Wei, W., Ye, L., Young, R. A., Livingston, D. M., & Parvin, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5605 · Cited by 454
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
Wilson, C., Ramos, L., Villaseñor, M. R., Anders, K. H., Press, M. F., Clarke, K., Karlan, B. Y., Chen, J.-J., Scully, R., Livingston, D. M., et al. (1999) · Nature Genetics · doi:10.1038/6029 · Cited by 414
Smith, S. A., Easton, D. F., Evans, D. G., & Ponder, B. A. J. (1992) · Nature Genetics · doi:10.1038/ng1092-128 · Cited by 410
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
Anderson, S. F., Schlegel, B. P., Nakajima, T., Wolpin, E. S., & Parvin, J. D. (1998) · Nature Genetics · doi:10.1038/930 · Cited by 393
Yu, X., Wu, L. C., Bowcock, A. M., Aronheim, A., & Baer, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25388 · Cited by 389
BRCA1 regulates p53-dependent gene expression
Ouchi, T., Monteiro, Á. N. A., August, A., Aaronson, S. A., & Hanafusa, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2302 · Cited by 375
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 353
Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
Li, S., Ting, N. S. Y., Zheng, L., Chen, P., Ziv, Y., Shiloh, Y., Lee, E. Y.-H. P., & Lee, W. (2000) · Nature · doi:10.1038/35018134 · Cited by 336
Insights into the functions of BRCA1 and BRCA2
Welcsh, P. L., Owens, K. N., & King, M. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01930-7 · Cited by 335
Self-citationBRCA1 interacts with components of the histone deacetylase complex
Yarden, R. I., & Brody, L. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4983 · Cited by 328
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin, R. L., Nemeth, E., Tran, H., Shvartsman, H. S., Cass, I. A., Narod, S. A., & Karlan, B. Y. (2000) · PubMed · Cited by 324
BRCA1 is associated with the centrosome during mitosis
Hsu, L., & White, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12983 · Cited by 312
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y.-X., Wang, C.-G., Yuan, R., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I., Webb, P., Kushner, P., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 293
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.Preprint
Smith, T., Lee, M. K., Szabo, C., Jerome, N., Mceuen, M., Taylor, M. P., Hood, L., & King, M. (1996) · Genome Research · doi:10.1101/gr.6.11.1029 · Cited by 291
Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W. J., Daly, P. A., Ford, D., & Easton, D. F. (1995) · PubMed · Cited by 243
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
Wang, Q., Zhang, H., Kajino, K., & Greene, M. I. (1998) · Oncogene · doi:10.1038/sj.onc.1202403 · Cited by 243
Zheng, L., Pan, H., Li, S., Flesken‐Nikitin, A., Chen, P., Boyer, T., & Lee, W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00075-7 · Cited by 232
Beger, C., Pierce, L. N., Krüger, M., Marcusson, E. G., Robbins, J. M., Welcsh, P. L., Welch, P. J., Welte, K., King, M., Barber, J. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.130 · Cited by 224
Self-citationCBP/p300 interact with and function as transcriptional coactivators of BRCA1
Pao, G. M., Janknecht, R., Ruffner, H., Hunter, T. R., & Verma, I. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1020 · Cited by 222
Unexpected relationships between four large deletions in the human β-globin gene cluster
Vanin, E. F., Henthom, P. S., Kioussis, D., Grosveld, F. G., & Smithies, O. (1983) · Cell · doi:10.1016/0092-8674(83)90103-4 · Cited by 210
Chen, C., Li, S., Chen, Y., Chen, P., Sharp, Z. D., & Lee, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32863 · Cited by 203
Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 202
Li, S., Chen, P., Subramanian, T., Chinnadurai, G., Tomlinson, G. E., Osborne, C. K., Sharp, Z. D., & Lee, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11334 · Cited by 192
Lessons learned from BRCA1 and BRCA2
Zheng, L., Li, S., Boyer, T., & Lee, W. (2000) · Oncogene · doi:10.1038/sj.onc.1203968 · Cited by 187
Marston, N. J., Richards, W. J., Hughes, D. A., Bertwistle, D., Marshall, C. J., & Ashworth, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4633 · Cited by 186
Chai, Y., Cui, J., Shao, N., Reddy, E. S. P., & Rao, V. N. (1999) · Oncogene · doi:10.1038/sj.onc.1202323 · Cited by 179
Yeh, S., Hu, Y.-C., Rahman, M., Lin, H.-K., Hsu, C.-L., Ting, H., Kang, H.-Y., & Chang, C. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.190353897 · Cited by 169
Schubert, E. L., Lee, M. K., Mefford, H. C., ARGONZA, R. H., Morrow, J. E., Hull, J., Dann, J. L., & King, M. (1997) · PubMed · Cited by 166
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
Deng, C., & Scott, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203269 · Cited by 163
Characterization of a carboxy-terminal BRCA1 interacting protein
Wong, A. K. C., Ormonde, P. A., Pero, R. S., Chen, Y., Lian, L., Salada, G. C., Berry, S., Lawrence, Q. A., Dayananth, P., Ha, P. C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202150 · Cited by 162
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S. E., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Unger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D. E., Shih, H. A., Martin, A., Lenoir, G., Mazoyer, S., & Weber, B. L. (2000) · The American Journal of Human Genetics · doi:10.1086/303076 · Cited by 157
Nuclear structure and the three‐dimensional organization of DNA
Getzenberg, R. H., Pienta, K. J., Ward, W. S., & Coffey, D. S. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470402 · Cited by 152
Marmorstein, L. Y., Kinev, A. V., Chan, G. K. T., Bochar, D. A., Beniya, H., Epstein, J. A., Yen, T. J., & Shiekhattar, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00209-4 · Cited by 147
Wang, H., Shao, N., Ding, Q. M., Cui, J., Reddy, E. S. P., & Rao, V. N. (1997) · Oncogene · doi:10.1038/sj.onc.1201252 · Cited by 130
Regulation of BRCA1 Expression by the Rb-E2F Pathway
Wang, A., Schneider‐Broussard, R., Kumar, A. P., MacLeod, M. C., & Johnson, D. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4532 · Cited by 122
Li, S., Ku, C.-Y., Farmer, A. A., Cong, Y.-S., Chen, C., & Lee, W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6183 · Cited by 121
BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site
Ruffner, H., Jiang, W. B., Craig, A. G., Hunter, T. R., & Verma, I. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4843 · Cited by 115
BRCA2 associates with acetyltransferase activity when bound to P/CAF
Fuks, F., Milner, J., & Kouzarides, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202475 · Cited by 107
Collins, N., Wooster, R., & Stratton, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.526 · Cited by 103
Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
Arizti, P., Li, F., Park, I., Yin, Y., Solomon, E., Ouchi, T., Aaronson, S. A., & Lee, S. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7450-7459.2000 · Cited by 102
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13
Cleton-Jansen, A. M., Collins, N., Lakhani, S. R., Weissenbach, J., Devilee, P., Cornelisse, C., & Stratton, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.493 · Cited by 98
MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi, P., Hedenfalk, I. A., Persson, K., Duggan, D. J., Tanner, M., Johannsson, O. T., Olsson, H. L., Trent, J. M., Isola, J. J., & Borg, Å. (2000) · PubMed · Cited by 94
Nordling, M., Karlsson, P., Wahlström, J., Engwall, Y., Wallgren, A., & Martinsson, T. (1998) · PubMed · Cited by 93
BRCA1: exploring the links to transcription
Monteiro, Á. N. A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01632-7 · Cited by 87
Wang, Q., Zhang, H., Fishel, R. A., & Greene, M. I. (2000) · Oncogene · doi:10.1038/sj.onc.1203974 · Cited by 87
Overexpression of BRCA2 gene in sporadic breast tumours
Bièche, I., Noguès, C., & Lidereau, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202903 · Cited by 77
Zhang, H., Wang, Q., Kajino, K., & Greene, M. I. (2000) · DNA and Cell Biology · doi:10.1089/10445490050021168 · Cited by 74
Jackson, D. A., Bartlett, J., & Cook, P. R. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.7.1212 · Cited by 74
DNA loops: structural and functional properties of scaffold‐attached regions
Roberge, M., & Gasser, S. M. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01485.x · Cited by 70
Budhram-Mahadeo, V. S., Ndisang, D., Ward, T., Weber, B. L., & Latchman, D. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203072 · Cited by 69
DNA polymerase stalling, sister chromatid recombination and the BRCA genes
Scully, R., Puget, N., & Vlasáková, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203971 · Cited by 68
Jack, R. S., & Eggert, H. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17314.x · Cited by 67
BRCA1 Physically and Functionally Interacts with ATF1
Houvras, Y. J., Benezra, M., Zhang, H., Manfredi, J. J., Weber, B. L., & Licht, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002539200 · Cited by 66
Schlegel, B. P., Green, V. J., Ladias, J. A. A., & Parvin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3148 · Cited by 63
Yamane, K., Katayama, E., & TSURUO, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3983 · Cited by 62
GA-binding protein α/β is a critical regulator of the BRCA1 promoter
Atlas, E., Stramwasser, M., Whiskin, K., & Mueller, C. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203516 · Cited by 55
Induction of the BRCA2 Promoter by Nuclear Factor-κB
Wu, K., Jiang, S. W., Thangaraju, M., Wu, G., & Couch, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004390200 · Cited by 54
The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins
Irminger‐Finger, I., Siegel, B., & Leung, W.-C. (1999) · Biological Chemistry · doi:10.1515/bc.1999.019 · Cited by 53
Low expression of bcl-2 in Brca1-associated breast cancers
Fréneaux, P., Stoppa‐Lyonnet, D., Mouret, E., Kambouchner, M., Nicolas, A., Sigal‐Zafrani, B., Vincent‐Salomon, A., Fourquet, A., Magdelénat, H., & Sastre‐Garau, X. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1438 · Cited by 51
Igfbp-3 mediates TGFβ1 proliferative response in colon cancer cells
Kansra, S., Ewton, D. Z., Wang, J., & Friedman, E. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000801)87:3 · Cited by 48
Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.
Futamura, M., Arakawa, H., Matsuda, K., Katagiri, T., Saji, S., Miki, Y., & Nakamura, Y. (2000) · PubMed · Cited by 48
The frequency and distribution of sister chromatid exchanges in human chromosomes
Morgan, W. F., & Crossen, P. E. (1977) · Human Genetics · doi:10.1007/bf00402152 · Cited by 37
The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase
Milner, J., Fuks, F., Hughes‐Davies, L., & Kouzarides, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203793 · Cited by 25
BRCA1-associated growth arrest is RB-dependent
Bessho, M., Kuthiala, A., Meissner, E. G., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kgh8-cv59 · Cited by 19
TGF-β1 Inhibits BRCA1 Expression through a Pathway That Requires pRb
Satterwhite, D. J., Matsunami, N., & White, R. L. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3510 · Cited by 15
Jack, R. S., & Eggert, H. (1993) · Springer eBooks · doi:10.1007/978-3-642-78046-2_18 · Cited by 3
Flagged first, then by citations
1 of the 93 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903387 · Cited by 2,302
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Gelmon, K. A., Tischkowitz, M. D., MacKay, H. J., Swenerton, K. D., Robidoux, A., Tonkin, K. S., Hirte, H. W., Huntsman, D. D., Clemons, M. J., Gilks, C. B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,130
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Metadata
- Authors
- Welcsh, P. L.
- Affiliations
- University of Washington (US)
- Corresponding author
- Welcsh, P. L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-04-01
- Volume
- 10
- Issue
- 7
- Pages
- 705-713
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2124371549
- Cited by
- 648
- References
- 93
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 25 · 2023: 19 · 2022: 19 · 2021: 26 · 2020: 27 · 2019: 33 · 2018: 30 · 2017: 36 · 2016: 34 · 2015: 31 · 2014: 29 · 2013: 25 · 2012: 17
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca027632-22)
- National Cancer Institute (CA27632)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BRCA2, hereditary breast cancer, hereditary ovarian cancer, germline mutations, somatic mutations, DNA repair, transcriptional regulation, repetitive elements, chromosomal instability, genome rearrangement, carcinogenesis, tumor suppressor
- MeSH terms
- Breast Neoplasms, Cell Division, Chromosomes, Estrogens, Female, Humans, Models, Biological, Mutation, Neoplasm Proteins, Ovarian Neoplasms, Repetitive Sequences, Nucleic Acid, Transcription Factors, Gene Deletion, Genes, BRCA1, Genetic Predisposition to Disease, BRCA2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review